Concepedia
2
Publications
785
Citations
H-Index
2002
Active since
Affiliations
Novo Nordisk (Denmark)(Current)
B. Elbrønd is an author at Novo Nordisk (Denmark) specializing in clinical pharmacology, pharmacotherapy, and physiology.
Top concepts
MedicinePhysiologyPharmacologyEndocrinologyPharmacotherapyClinical Pharmacology
Publications per year
2002–2002
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
Henrik Agersø, Lene Jensen, B. Elbrønd et al. · Diabetologia · 2002 · 503 citations · Full text
Physiology, Pharmacology, Clinical Pharmacology +5
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects
B. Elbrønd, Grethe Jakobsen, Søren Erik Larsen et al. · Diabetes Care · 2002 · 282 citations · Full text
Rows per page
1–2 of 2